Metabogen Ab

Biogaia Ab

Proprev Ab

Fredrik Backhed

Muhammad-Tanweer Khan

Inger Björck

Petia Kovatcheva-Datchary

Anne Nilsson

Valentina Tremaroli

Fredrik H Karlsson

Jens Nielson

Bjorn Fagerberg

A product such as a food product, food ingredient, food supplement or medicament containing isolated(). The food product, food ingredient and food supplement are suitable for ingestion and the medicament is suitable for use as a suppository or enema or enclosed in a capsule.

compositions

The present invention relates generally to medicine. More specifically the invention relates to the use of synergistic probiotic bacteria as intervention for health. In particular, the present invention provides a strain ofand a bacterial strain which has one or more of the characteristics of: (i) being acetate producing, (ii) being lactate consuming and (iii) having the ability to be an electron acceptor, for use in the treatment or prevention of a disease associated with reduced butyrate levels or a disease associated with reduced or low numbers ofbacteria.

andfor use in the treatment or prevention of diabetes and bowel diseases

The present invention relates generally to growth of bacteria. More specifically the invention relates to a method for oxidative environment adaptation of anaerobic microorganisms and their use in developing new probiotics. In particular, the present invention provides a method for adaptation of anaerobic microorganisms and selection of more oxygen tolerant anaerobic microorganisms, said method comprising the steps of culturing said microorganisms with a stepwise dual induction of oxidative stress via applied voltage and oxygen diffusion, and a stepwise change of anti-oxidant/oxidized counterpart concentration ratio to adjust the redox state. New strains are also provided.

Method for adaptation

A product for use in the treatment of obesity, the metabolic syndrome, type 2 diabetes, cardiovascular diseases, dementia, alzheimers disease and inflammatory bowel disease comprising at least one isolated bacterial strain from the species, wherein the strain is selected from the group consisting of25A and. The product may be a food product.

[object Object]

The present invention relates to the identification of a person having risk for developing type 2 diabetes (T2D) by determining the presence or absence of specific genes, gene clusters, genera or species of bacteria in the person's gastrointestinal microbiota. More specifically the invention relates to a model to identify an individual having or at risk of developing type 2 diabetes (T2D) using metagenomic clusters (MGCs), wherein said model is characterized by using different metagenomic clusters for different population groups. Also provided is the use of such a model in the identification of a person having risk for developing type 2 diabetes (T2D).

Growing community of inventors

Kullavik, Sweden

Fredrik Backhed